Skip to main content

Day: December 30, 2019

Flushing Financial Corporation to Host Fourth Quarter 2019 Earnings Call

UNIONDALE, N.Y., Dec. 30, 2019 (GLOBE NEWSWIRE) — Flushing Financial Corporation (the “Company”) (Nasdaq-GS: FFIC), the parent holding company for Flushing Bank (the “Bank”), today announced that it will release its fourth quarter 2019 earnings after the market closes on Thursday, January 30, 2020.John R. Buran, President and Chief Executive Officer, and Susan K. Cullen, Senior Executive Vice President and Chief Financial Officer, will host the conference call on Friday, January 31, 2020 at 9:30 AM (ET) to discuss the Company’s strategy and results for the fourth quarter of 2019.   Interested parties are invited to listen in by dialing 1-877-509-5836. The conference call will be simultaneously webcast at https://services.choruscall.com/links/ffic200131.html and archived through January 31,...

Continue reading

CRCAM Alpes Provence : Déclarations_Hebdomadaires_CAAP_S52-2019

CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL ALPES PROVENCE                                                                                             Société coopérative à capital variable25, Chemin des trois cyprès 13097 Aix en Provence Cedex 2381 976 448 R.C.S Aix en ProvenceAix-en-Provence, le 30 décembre 2019Achats effectués dans...

Continue reading

SPINEWAY : ERRATUM – First subscription phase in linked with NEGMA GROUP’s agreement

SPINEWAYERRATUMFirst subscription phase pursuant to the agreement for the issue of tranche warrants granting rights to exercise bonds convertible into new ordinary shares with warrants entered into with NEGMA GROUP LTD on 16 October 2019Minimum of €5.3M by 31 March 2020In accordance with:the delegation of power granted by the Extraordinary Shareholders’ Meeting held by Spineway (the “Company”) on 3 October 2019;the Board of Directors’ decision of 17 October 2019 approving the issue of 16 000 warrants (the “Tranche Warrants”) the exercise of which gives access to the issue of a maximum of 16 000 bonds convertible into new ordinary shares (the “Convertible Bonds”) with warrants (the “Warrants”), representing a bond issue for a maximum total par value of 40 000 000...

Continue reading

SPINEWAY : ERRATUM – 1ere phase de souscription dans le cadre du contrat avec NEGMA GROUP

SPINEWAYERRATUM1ère phase de souscription dans le cadre du contrat de bons d’émission ouvrant droit à l’exercice d’obligations convertibles en actions ordinaires nouvelles assorties de bons de souscription d’actions conclu avec NEGMA GROUP LTD en date du 16 octobre 2019Montant minimal de 5,3 M€ d’ici au 31 mars 2020Conformément à :la délégation de compétence conférée par l’Assemblée Générale Extraordinaire des actionnaires de Spineway (la « Société ») le 3 octobre 2019 ;la décision du Conseil d’administration de la Société, en date du 17 octobre 2019, ayant décidé de l’émission de 16 000 bons d’émission...

Continue reading

Microbot Medical Inc. Announces Closing of $10.0 Million Registered Direct Offering of Common Stock

HINGHAM, Mass., Dec. 30, 2019 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq:MBOT) closed its previously announced registered direct offering of 952,383 shares of its common stock at a purchase price of $10.50 per share for total gross proceeds of approximately $10.0 million, before deducting placement agent fees and offering expenses.Microbot currently intends to use the net proceeds from this offering for the continuous development and regulatory activities for its SCS device for the treatment of hydrocephalus and NPH; continue the development of the Company’s LIBERTY robotic system, including its expansion through addition of complementary assets to it either through internal development, in-license or acquisitions; expand and develop additional applications deriving from its existing IP portfolio, either through internal...

Continue reading

GUERBET : Déclaration des opérations sur actions propres du 23 au 27 décembre 2019 (agrégée)

Villepinte (France), le 30 décembre 2019La présentation détaillée transaction par transaction est disponible via le lien suivant :  https://bit.ly/39tlyhlPionnier dans le domaine des produits de contraste avec plus de 90 années d’expérience, Guerbet est un des leaders de l’imagerie médicale au niveau mondial. Il dispose d’une gamme complète de produits pharmaceutiques, de dispositifs médicaux et de services pour l’imagerie diagnostique et interventionnelle afin d’améliorer la prise en charge thérapeutique des patients. Avec 8 % de ses ventes consacrées à la R&D et plus de 200 collaborateurs répartis dans 4 centres en France, en Israël et aux États-Unis, Guerbet mobilise...

Continue reading

Nestlé completes CHF 20 billion share buyback program, will start new share buyback program of up to CHF 20 billion

 Vevey, December 30, 2019Nestlé completes CHF 20 billion share buyback program, will start new share buyback program of up to CHF 20 billionNestlé S.A. today announced that it has completed its 20 billion share buyback program initiated on July 4, 2017. Since July 4, 2017, Nestlé has repurchased 225,186,059 of its shares for a total of CHF 20 billion at an average purchase price per share of CHF 88.82.A total of 136,160,000 repurchased shares were cancelled by the Annual General Meetings held on April 12, 2018 and on April 11, 2019. As a result, the share capital of Nestlé S.A. was reduced to currently CHF 297,600,000. The Annual General Meeting 2020 of Nestlé S.A. will decide upon the cancellation of the remaining 89,026,059 repurchased shares.Nestlé S.A. will start a new share buyback program...

Continue reading

Grant of warrants

December 30, 2019Announcement no. 22Grant of warrantsToday, the Board of Directors of BioPorto A/S (“BioPorto”) (Nasdaq: BIOPOR) has decided to exercise part of the current authorization by issuing 250,000 warrants to one of the Company’s key employees.The warrants are issued in accordance with the company’s Remuneration policy and guidelines for incentive-based remuneration and the authorization in section 18 of the Articles of Association.Each warrant grants the holder the right to subscribe for one share in the Company. The exercise price is fixed at DKK 2.90 per share corresponding to the last 10 days volume weighted average price of BioPorto’s stock traded on Nasdaq Copenhagen A/S. The warrants will be exercisable in the period from December 30, 2021 – December 29, 2024. Within the exercise period,...

Continue reading

ASMI Share Buyback Update December 23 – 27, 2019

Almere, The NetherlandsDecember 30, 2019, 5:45 p.m. CETASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASMI’s current share buyback program.These repurchases were made as part of the €100 million share buyback program announced on November 1, 2019. Of the total program, 96.2% has been repurchased. For further details including individual transaction information please visit:www.asm.com/investors/share-information/share-buyback.About ASM InternationalASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participations provide production solutions for wafer processing (Front-end segment) as well as for assembly...

Continue reading

Issue of new VINCI shares, reserved for group employees in France in the context of its savings plan

A public limited company (société anonyme) with a share capital of €1,513,094,222.50Registered office: 1, cours Ferdinand de Lesseps92500 Rueil-MalmaisonRegistration number 552 037 806 RCS Nanterrewww.vinci.comShareholders relations department: actionnaires@vinci.com____________________________________Issue of new VINCI shares,reserved for group employees in Francein the context of its savings plan¨The combined general meeting of shareholders held on 17 April 2019, through its 25th resolution, delegated to the Board of directors its power to make increases in the capital reserved for employees for a period of 26 months expiring on 16 June 2021.The meeting of shareholders defined in this context the manner in which the issue price of the new shares is determined.During its meeting held on 18 October 2019,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.